Browse Drug Recalls
2,085 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,085 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,085 FDA drug recalls in 2013.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 11, 2013 | Oxiracetam & Choline , Oxiracetam 460mg Choline 110mg capsules a) 30 count bo... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Aniracetam & Choline capsules, 430mg Aniracetam 88mg Choline, a) 30 count bot... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 coun... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | BoostYourGrade.com, Piracetam 390mg Choline 104mg capsules, 250 count bottle,... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Acetic Acid Otic Solution, USP, 15 mL bottle, Rx Only, Hi-Tech Pharmacal Co.,... | Subpotent Drug: The product/lot is out-of-specification (OOS) for the assay of acetic acid at the... | Class III | Hi-Tech Pharmacal Co., Inc. |
| Mar 11, 2013 | Piracetam & Choline, 390mg Piracetam 104mg Choline Capsules, a) 30 count bott... | Marketed Without an Approved NDA/ANDA: The products are unapproved drugs | Class II | Palmer Natural Products |
| Mar 11, 2013 | Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Speci... | Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye i... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 11, 2013 | Night Bullet Capsules, supplied in 1 count packets, produced by Green Planet ... | Marketed Without an Approved NDA/ANDA; product contains analogues of sildenafil and tadalafil whi... | Class I | Green Planet Inc |
| Mar 11, 2013 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-... | Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel parti... | Class II | Gsms |
| Mar 7, 2013 | 4 way Saline Moisturizing Mist with Eucalyptol & Menthol, 1-fl. oz. bottles, ... | Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be ... | Class III | Novartis Consumer Health |
| Mar 7, 2013 | Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. t... | Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be ... | Class III | Novartis Consumer Health |
| Mar 7, 2013 | Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd... | Subpotent drug: low fill volume in some of the capsules | Class II | Sanofi US |
| Mar 7, 2013 | 4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydroc... | Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be ... | Class III | Novartis Consumer Health |
| Mar 7, 2013 | 4 way Nasal Decongestant Fast Acting Nasal Spray, containing phenylephrine hy... | Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be ... | Class III | Novartis Consumer Health |
| Mar 7, 2013 | Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-... | Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be ... | Class III | Novartis Consumer Health |
| Mar 5, 2013 | Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx o... | Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/o... | Class II | Zydus Pharmaceuticals USA Inc |
| Mar 4, 2013 | SEPP 10% Povidone Iodine Solution USP (1% available Iodine, Surfactant & USP ... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | Donor Prep Kit containing 1 FREPP (70% isopropyl alcohol), Net 1.1 mL and 1 S... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | SEPP 70% Isopropanol (isopropyl alcohol) 70% v/v, USP, 200-count applicators ... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | FREPP/SEPP Kit containing 1 FREPP (povidone iodine 2% aqueous solution), Net ... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodiu... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | Blood Culture Prep Kit II containing 1 FREPP (70% isopropyl alcohol), Net 1.1... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 2, 2013 | Voltaren 1% Gel, 100 gm tube, Rx only, Dist By: Physicians Total Care, Tulsa ... | Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is being initiated because... | Class III | Physicians Total Care, Inc. |
| Feb 27, 2013 | Fenofibric Acid, immediate release tablet, 105 mg, a) 30 count bottle (NDC 5... | Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in ... | Class III | Mutual Pharmaceutical Company, Inc. |
| Feb 27, 2013 | FIBRICOR (fenofibric acid) Tablets, 105 mg, a) 30 count bottle (NDC 13310-102... | Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in ... | Class III | Mutual Pharmaceutical Company, Inc. |
| Feb 27, 2013 | Fenofibric Acid, immediate release tablet, 35 mg, 30 count bottle Rx only, Mu... | Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in ... | Class III | Mutual Pharmaceutical Company, Inc. |
| Feb 27, 2013 | 0.9% Sodium Chloride Injection, USP, 50 mL Mini-Bag Plus Container, Rx only, ... | Labeling Wrong Barcode; It may display wrong product code reflecting 0.9% Sodium Chloride Injec... | Class II | Baxter Healthcare Corp. |
| Feb 26, 2013 | Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, ... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 26, 2013 | Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx on... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 26, 2013 | QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, ... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 26, 2013 | Lisinopril Tablets, USP 10 mg, Rx only, 1000 count bottles, Manufactured for... | Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identif... | Class III | Mylan Pharmaceuticals Inc. |
| Feb 26, 2013 | Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manu... | Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some caps... | Class II | Sanofi-Synthelabo |
| Feb 26, 2013 | Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0... | Defective Container: This recall is being carried out due to the potential for improperly sealed ... | Class II | Teva Pharmaceuticals USA, Inc. |
| Feb 26, 2013 | Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Flip... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 25, 2013 | Propofol Injectable Emulsion, 1%, packaged in a) 5 x 20 mL Single patient inf... | Presence of Particulate Matter: Visible particulate embedded in vials was observed and confirmed ... | Class II | Hospira Inc. |
| Feb 22, 2013 | Ethambutol Hydrochloride Tablets USP, 400 mg, 100-count bottles, Rx only, Man... | Failed Impurities/Degradation Specifications: This product is being recalled due to an out of spe... | Class III | Lupin Pharmaceuticals Inc. |
| Feb 22, 2013 | Fludeoxyglucose F 18 Injection USP, 20-200 mCi/mL, Diagnostic - For Intraveno... | cGMP Deviation | Class II | Petnet Solution Inc |
| Feb 19, 2013 | Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream 1% Antifungal, No... | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the ... | Class III | Novartis Consumer Health |
| Feb 19, 2013 | Novartis Lamisil AT Cream for Jock Itch (terbinafine hydrochloride 1% antifun... | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the ... | Class III | Novartis Consumer Health |
| Feb 19, 2013 | Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) T... | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the ... | Class III | Novartis Consumer Health |
| Feb 19, 2013 | Voltaren Gel (diclofenac sodium topical gel) 1%, for topical use only, RX onl... | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the ... | Class III | Novartis Consumer Health |
| Feb 19, 2013 | Target Up & Up, athlete's foot cream, full prescription strength, terbinafine... | Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the ... | Class III | Novartis Consumer Health |
| Feb 18, 2013 | 0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., La... | Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrec... | Class II | Hospira Inc. |
| Feb 18, 2013 | PE Daytime Cold/Flu LiqGel, Multi Symptom Relief, Acetaminophen/Dextromethorp... | Subpotent; 12 month time point for the active ingredient Phenylephrine HCl. | Class III | L. Perrigo Co. |
| Feb 15, 2013 | Amoxicillin for Oral Suspension, 125mg/5mL, a) 80 mL (NDC 43598-222-80); b) ... | Microbial Contamination of Non-Sterile Products: Suspensions made from these lots of Amoxicillin ... | Class II | Dr Reddys Laboratories Tennessee LLC |
| Feb 15, 2013 | Femhrt (norethindrone acetate and ethinyl estradiol) tablets, 1.0 mg/5.0 mcg,... | Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the produ... | Class III | Warner Chilcott Company LLC |
| Feb 15, 2013 | METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira,... | Lack of Assurance of Sterility: There is the potential for the solution to leak from the administ... | Class II | Hospira Inc. |
| Feb 15, 2013 | Femhrt (norethindrone acetate and ethinyl estradiol) tablets, 0.5 mg/2.5 mcg... | Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the produ... | Class III | Warner Chilcott Company LLC |
| Feb 15, 2013 | Jevantique (norethindrone acetate and ethinyl estradiol) tablets; 1.0 mg/5.0 ... | Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the produ... | Class III | Warner Chilcott Company LLC |
| Feb 13, 2013 | Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per... | Chemical Contamination: The recall has been initiated based on multiple complaints received from ... | Class III | Glenmark Generics Inc., USA |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.